Ignite Creation Date:
2024-05-06 @ 7:50 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02601911
Status:
COMPLETED
Last Update Posted:
2016-09-20
First Post:
2015-10-27
Brief Title:
Effect of Premedication on Success of Inferior Alveolar Nerve Block Injection
Sponsor:
Azad University of Medical Sciences
Organization:
Azad University of Medical Sciences
Study Overview
Official Title:
Comparison of Ketorolac and KetorolacAcetaminophen on Success of Inferior Alveolar Nerve Block Injection
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is effect of premedication on success of inferior alveolar nerve block injection Sixty healthy adult volunteers including criteria are participating The patients will be divided into 3 groups and will be randomly given one of premedications including 1 10 mg Ketorolac 2 10 mg Ketorolac plus 1000mg Acetaminophen and 3Placebo 45 minutes before applying the injection All patients will receive standard Inferior Alveolar Nerve Block injection Patients with no lip numbness and positive responses to cold and electric pulp tests would be excluded from the study Endodontic access preparation will be initiated 15 minutes after Inferior Alveolar Nerve Block injection Pain during treatment will be recorded using a Heft parker Visual Analog ScaleVAS Success will be considered as no or mild pain VAS54 during cariesdentin removal access cavity preparation and working lengths measurements Data will be analysed using Mann-U-Whitney and Kruskal-wallis tests
Detailed Description:
The aim of this study is effect of premedication on success of inferior alveolar nerve block injection Sixty healthy adult volunteers with including criteria and with no spontaneous pain reporting no or mild Visual analog scale54 pain in response to cold testing and electric pulp tester are participating The patients will be divided into 3 groups on a random basis and will be randomly given one of the oral medications including 1 10 mg Ketorolac 2 10 mg Ketorolac plus 1000mg Acetaminophen and 3Placebo 45 minutes before applying the injection All patients will receive standard Inferior Alveolar Nerve Block injection with one carpule of 4 Articaine with 1100000 Epinephrine Patients with no anesthetic sign lip numbness and positive responses to cold and electric pulp tests would be excluded from the study Endodontic access preparation will be initiated 15 minutes after Inferior Alveolar Nerve Block injection Pain during treatment will be recorded using a Heft parker Visual Analog ScaleVAS Success will be considered as no or mild pain VAS54 during cariesdentin removal access cavity preparation and working lengths measurements Data will be analysed using Mann-U-Whitney and Kruskal-wallis tests
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None